Table 1.
Univariate and multivariate Cox proportional risk regression analysis of ASF1B.
| Characteristics | Total (N) | Univariate analysis | Multivariate analysis | ||
|---|---|---|---|---|---|
| Hazard ratio (95% CI) | P value | Hazard ratio (95% CI) | P value | ||
| ASF1B | 370 | 1.570 (1.320–1.867) | .018 | 1.771(1.611–1.892) | .047 |
| Low | 185 | ||||
| High | 185 | ||||
| Age | 367 | 1.620 (1.154–2.276) | .005 | 1.931 (1.336–2.791) | <.001 |
| ≤65 | 163 | ||||
| >65 | 204 | ||||
| Gender | 370 | 1.267 (0.891–1.804) | .188 | 1.254 (0.867–1.815) | .230 |
| Female | 133 | ||||
| Male | 237 | ||||
| Pathologic stage | 347 | 1.947 (1.358–2.793) | <.001 | 1.818 (1.256–2.630) | .002 |
| Stage I and Stage II | 160 | ||||
| Stage III and Stage IV | 187 | ||||
| Histologic grade | 361 | 1.353 (0.957–1.914) | .087 | 1.363 (0.938–1.980) | .104 |
| G1&G2 | 144 | ||||
| G3 | 217 | ||||
ASF1B = anti-silencing function 1B.